Literature DB >> 518392

Intraocular penetration of subconjunctivally administered 14C-fluorouracil in rabbits.

J Rootman, J Tisdall, G Gudauskas, A Ostry.   

Abstract

Fluorouracil is given for a variety of neoplasms by various administrative routes. Toxicity of susceptible normal tissue limits systemic dosage, but at this level intraocular tissue may not receive tumor-inhibiting concentrations. Subconjunctival administration of 6.25 mg of 14C-fluorouracil in 0.5-mL dosages resulted in a peak anterior chamber concentration of 69.5 micrograms/mL and a peak vitreous concentration of 10.5 micrograms/mL over the 12 hours tested. This resulted in no visible ocular damage. The intraocular levels achieved were greater than the concentration reported to inhibit selected tumors. The total dosage administered was considerably below the level of systemic toxicity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 518392     DOI: 10.1001/archopht.1979.01020020591019

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  9 in total

1.  Effects of subconjunctival 5-fluorouracil injections on the corneal endothelium and ciliary epithelium.

Authors:  M Araie; Y Nakano; T Akahoshi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

Review 2.  The clinical applications of fluorouracil in ophthalmic practice.

Authors:  Lekha M Abraham; Dinesh Selva; Robert Casson; Igal Leibovitch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Effects of selected repeated intravitreal chemotherapeutic agents.

Authors:  J Vernot; G A Peyman; R Gailitis; R Fiscella; M Woodhouse; D Weinberg
Journal:  Int Ophthalmol       Date:  1985-11       Impact factor: 2.031

4.  Pharmacokinetics of a 5-fluorouracil liposomal delivery system.

Authors:  S T Simmons; M B Sherwood; D A Nichols; R B Penne; T Sery; G L Spaeth
Journal:  Br J Ophthalmol       Date:  1988-09       Impact factor: 4.638

5.  Inhibition of experimental intraocular proliferation with intravitreal 5-fluouracil.

Authors:  S Binder; B Riss; C Skorpik; W Kulnig
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

6.  Topical application of 5-fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid.

Authors:  R J de Keizer; D de Wolff-Rouendaal; J L van Delft
Journal:  Doc Ophthalmol       Date:  1986-12-30       Impact factor: 2.379

7.  Liposome-encapsulated 3H-5FU in rabbits.

Authors:  P Fishman; G A Peyman; R Hendricks; S L Hui
Journal:  Int Ophthalmol       Date:  1989-09       Impact factor: 2.031

8.  Effect of postoperative subconjunctival 5-fluorouracil injections on the surgical outcome of trabeculectomy in the Japanese.

Authors:  Y Nakano; M Araie; S Shirato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

9.  Ocular absorption and toxicity of methotrexate in the dog.

Authors:  M N Bussanich; J Rootman; C Kumi; G Gudauskas
Journal:  Can Vet J       Date:  1985-09       Impact factor: 1.008

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.